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Our laboratory has previously demonstrated that daily forced swim stress (FSS) prior
to ethanol drinking sessions facilitates enhanced ethanol consumption in mice with
a history of chronic intermittent ethanol (CIE) vapor exposure without altering ethanol
intake in air-exposed controls. Because both stress and chronic ethanol exposure have
been shown to activate the dynorphin/kappa opioid receptor (KOR) system, the present
study was designed to explore a potential role for KORs in modulating stress effects on
ethanol consumption in the CIE model of dependence and relapse drinking. After stable
baseline ethanol intake was established in adult male C57BL/6J mice, subjects received
chronic intermittent exposure (16 h/day × 4 days/week) to ethanol vapor (CIE group) or
air (CTL group). Weekly cycles of inhalation exposure were alternated with 5-day limited
access drinking tests (1 h access to 15% ethanol). Experiment 1 compared effects of
daily FSS and KOR activation on ethanol consumption. CIE and CTL mice were either
exposed to FSS (10 min), the KOR agonist U50,488 (5 mg/kg), or a vehicle injection
(non-stressed condition) prior to each daily drinking session during test weeks. FSS
selectively increased drinking in CIE mice. U50,488 mimicked this effect in CIE mice, but
also increased drinking in CTL mice. Experiment 2 assessed effects of KOR blockade
on stress-induced drinking in CIE and CTL mice. Stressed and non-stressed mice
were administered the short-acting KOR antagonist LY2444296 (0 or 5 mg/kg) 30 min
prior to each drinking session during test weeks. FSS selectively increased ethanol
consumption in CIE mice, an effect that was abolished by LY2444296 pretreatment.
In Experiment 3, CIE and CTL mice were administered one of four doses of U50,488
(0, 1.25, 2.5, 5.0 mg/kg) 1 h prior to each daily drinking test (in lieu of FSS). All doses
of U50,488 increased ethanol consumption in both CIE and CTL mice. The U50,488-
induced increase in drinking was blocked by LY2444296. Our results demonstrate that
the KOR system contributes to the stress enhancement of ethanol intake in mice with a
history of chronic ethanol exposure.
Keywords: ethanol, stress, kappa opioid receptor, dynorphin, mice
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INTRODUCTION
It is generally recognized that stress exposure may significantly
contribute to the initiation of ethanol drinking and perpetuate
continued ethanol use (Brady and Sonne, 1999). In this
way, stress may facilitate transition from social (regulated)
ethanol use to more excessive levels of consumption that
can lead to the development of alcohol dependence in
humans (Uhart and Wand, 2009). In ethanol-dependent
individuals attempting abstinence, stress is known to serve as
a potent trigger for relapse drinking (Sinha, 2012). Increased
relapse vulnerability continues to be a major impediment to
treatment of alcohol use disorders. Elucidation of the underlying
mechanisms that contribute to stress-induced drinking may
ultimately lead to the development of new and more effective
treatment strategies for alcoholism. Although demonstrating
stress-induced increases in ethanol consumption using animal
models has proven challenging (cf. Becker et al., 2011), our
laboratory has recently developed a model that demonstrates
stress-induced enhancement of ethanol drinking in mice with
a history of chronic intermittent ethanol (CIE) exposure
(Lopez et al., 2016). As such, this model is well suited
for studying mechanisms that contribute to this apparent
unique interaction of stress with ethanol in the context of
dependence.
The endogenous opioid system, which includes endorphins,
enkephalins, and dynorphins, has been widely implicated
in the motivational effects of ethanol through actions at
mu, delta, and kappa opioid receptors (KORs). While mu
and delta receptors influence ethanol’s rewarding effects,
ethanol dependence-related drinking has been shown to
be more sensitive to antagonism by KOR antagonists
(Kissler et al., 2014). Several reports have indicated that
naltrexone, a general opioid antagonist with greatest
affinity for mu receptors, does not attenuate stress-induced
reinstatement of operant responding for ethanol (Lê et al.,
1999; Liu and Weiss, 2002). On the other hand, converging
molecular and behavioral evidence suggests that KORs
may pose a promising therapeutic target for attenuation of
stress-related ethanol consumption in alcohol-dependent
subjects.
KORs and their endogenous ligands, dynorphins
(derived from the precursor prodynorphin), are sensitive
to both chronic ethanol and stress exposure. For example,
exposure to various stressors has been shown to increase
immunoreactivity of Dynorphin A and Dynorphin B
in regions of the hippocampus and nucleus accumbens
(Shirayama et al., 2004). Similarly, 24 h after forced swim
stress (FSS) exposure, prodynorphin immunoreactivity is
increased in the dorsal bed nucleus of the stria terminalis
(dBNST) and the lateral central nucleus of the amygdala
(CeA; Chung et al., 2014), with elevated prodynorphin
mRNA in the nucleus accumbens also reported (Chartoff
et al., 2009). Various ethanol exposure regimens that
involve both experimenter-administered as well as self-
administered ethanol exposure have been reported to
increase prodynorphin mRNA levels and Dynorphin B
expression in the nucleus accumbens (Przewłocka et al., 1997;
Lindholm et al., 2000). More recent work has also shown
that KOR mRNA, preprodynorphin mRNA, and dynorphin
signaling are upregulated in the amygdala following chronic
ethanol exposure (D’Addario et al., 2013; Zhou et al., 2013;
Kissler et al., 2014). Thus, there is a convergent body of literature
that indicates both stress and ethanol exposure activate the
dynorphin/KOR system.
Supporting a role for the dynorphin/KOR system in behaviors
related to stress, activation of KORs has been shown to increase
behavioral measures of anxiety-like and depressive-like states.
For example, the KOR agonist U50,488 reduced open arm time
in the elevated plus maze in both mice (Bruchas et al., 2009) and
rats (Valdez and Harshberger, 2012). Complementary studies in
transgenic mice have reported that genetic deletion of dynorphin
produced an anxiolytic profile, as indexed by dynorphin knock-
out mice spending more time in the light side during a
light-dark box task relative to their wild-type counterparts
(Wittmann et al., 2009). KOR agonists have also been shown
to increase immobility in the FSS model of depressive-like
behavior whereas KOR antagonists typically reduce immobility
(Mague et al., 2003; McLaughlin et al., 2003; Beardsley et al.,
2005; Zhang et al., 2005; Carlezon et al., 2006; Carey et al.,
2009).
Exposure to various stressors has been previously shown
to increase the rewarding effects of ethanol and decrease the
aversive properties of ethanol (Matsuzawa et al., 1998; Funk
et al., 2004; Sperling et al., 2010). For example, exposure
to FSS was shown to enhance conditioned place preference
induced by ethanol, nicotine, and cocaine (Schindler et al.,
2010; Sperling et al., 2010; Smith et al., 2012). Interestingly,
activation of KORs was reported to mimic this stress-induced
enhancement of conditioned drug-related reward states. That is,
systemic administration of the KOR agonist U50,488 resulted in
a potentiation of ethanol-induced conditioned place preference
similar to that produced by FSS in mice (Sperling et al., 2010).
Comparable effects were observed with cocaine and nicotine
(McLaughlin et al., 2006; Schindler et al., 2010; Smith et al., 2012).
Additionally, pharmacological activation of KORs was shown to
reinstate ethanol responding in an operant conditioning model
of relapse (Funk et al., 2014). Cues associated with central
administration of U50,488 have also been shown to increase
ethanol self-administration in nondependent rats (Berger et al.,
2013).
In another series of studies, blockade of KORs was shown
to prevent escalation of ethanol self-administration induced by
CIE vapor exposure in rats. Specifically, the long-acting KOR
antagonist nor-binaltorphimine (nor-BNI) reduced ethanol self-
administration in rats exposed to CIE vapor, but not air-exposed
controls after either systemic or central administration (Walker
and Koob, 2008; Walker et al., 2011). Further, Walker and
colleagues have implicated the CeA as a locus of KOR-mediated
effects by demonstrating that site-specific infusion of nor-BNI
into the CeA reduces ethanol consumption in chronic ethanol-
exposed rats (Kissler et al., 2014).
Given that the dynorphin/KOR system plays a role in
mediating chronic ethanol effects as well as behavioral effects
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of stress, the current studies were designed to investigate the
role of KORs in stress-enhanced drinking in subjects with
a history of CIE exposure. Specifically, the effects of KOR
activation were compared with the effects of daily FSS exposure
on voluntary ethanol consumption in mice with a history of CIE
vapor exposure and air-exposed control (CTL) mice. FSS was
selected based on our previous findings that this stressor is more
effective at increasing ethanol consumption in the CIE drinking
model (Lopez et al., 2016). It was hypothesized that systemic
administration of a KOR agonist would mimic the effects of FSS
to augment drinking in CIE-exposed mice. Additionally, effects
of KOR blockade on FSS-enhanced drinking were also evaluated
in CIE and CTL mice.
MATERIALS AND METHODS
Subjects
A total of 231 male C57BL/6J mice ordered from Jackson
Laboratories (Bar Harbor, ME, USA) were individually housed
in standard polycarbonate cages with corncob bedding in
a temperature- and humidity-controlled AAALAC-accredited
facility. Subjects were maintained on a 12 h modified reverse
light/dark cycle with ad libitum access to food and water
throughout experimentation. Mice were at least 10 weeks old at
the start of each experiment. Subjects were treated in accordance
with the NIH Guide for the Care and Use of Laboratory Animals
(8th edition, National Research Council, 2011) under protocols
approved by the Institutional Animal Care and Use Committee
at the Medical University of South Carolina.
Drugs
The KOR agonist U50,488 (Tocris) was dissolved in
saline and briefly sonicated. Doses of 1.25–5.0 mg/kg
were administered intraperitoneally (i.p.) in a volume of
10 ml/kg body weight. The novel, short-acting KOR antagonist
LY2444296 ([(S)-3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-
1-yl)methyl) phenoxy)benzamide]; compound #25 described
in Mitch et al., 2011) was synthesized at Eli Lilly Research
Laboratories (Indianapolis, IN, USA) and was dissolved in
a saline/polysorbate 80 mixture and sonicated. LY2444296
(5 mg/kg) was also delivered via i.p. injection (10 ml/kg body
weight).
Chronic Intermittent Ethanol (CIE)
Exposure and Drinking Procedure
Starting 3 h into the dark cycle, subjects were given access to
one bottle containing 15% ethanol (v/v) for 1 h. After 4–6 weeks
of baseline drinking, subjects were matched for average ethanol
consumption during the final week of baseline and assigned
to an ethanol exposure condition. Mice were then subjected
to repeated weekly cycles of CIE vapor or air (CTL) exposure,
with 5-day ethanol drinking test sessions conducted during
intervening weeks. Each weekly cycle of CIE (or air) inhalation
exposure occurred in Plexiglas chambers and consisted of
16 h/day exposure for 4 consecutive days followed by a 3-day
forced abstinence period before the start of each drinking test
week, as previously described (Griffin et al., 2009).
Prior to placement in ethanol vapor chambers for each 16 h
exposure, subjects in the CIE condition received a loading dose
of ethanol (1.6 g/kg) mixed with the alcohol dehydrogenase
inhibitor pyrazole (1 mmol/kg) via intraperitoneal injection
(20 ml/kg). Ethanol was administered to initiate intoxication
and pyrazole was given to slow the clearance of ethanol, thereby
maintaining high, stable blood ethanol levels throughout each
of the 16 h bouts of ethanol vapor exposure (Griffin et al.,
2009). Chamber ethanol concentrations were monitored daily
and blood samples were collected from the retroorbital sinus
on a weekly basis to ensure that ethanol exposure resulted in
blood ethanol concentrations (BECs) within the target range
of 175–225 mg/dl. All blood samples were centrifuged and the
plasma was assayed using an Analox ethanol analyzer. Mice in
the CTL condition were handled similarly, but received injections
of pyrazole mixed in saline (rather than ethanol) prior to air
exposure in inhalation chambers. A procedure overview for each
study is depicted in Figure 1 and described in detail below.
Forced Swim Stress Procedure
Mice assigned to the stress condition were exposed to forced
swim stress (FSS) for 10 min each day during test weeks following
inhalation exposure. FSS exposure occurred in glass cylinders
(40 cm high, 20 cm diameter) that were half-filled with 23–25◦C
tap water and separated by foam board dividers. Upon removal
from the cylinders, subjects were hand-dried and allowed to
recover on a heating pad for 5–10 min before returning to
the colony room. Water in each cylinder was replaced between
subjects.
FIGURE 1 | Procedure overview. Each study consisted of a period of
baseline ethanol consumption followed by repeated 1-week cycles of CIE (or
air) exposure alternated with 1-week drinking test weeks. During test weeks in
Experiment 1, CIE and CTL mice were subjected to one of three conditions: a
10-min forced swim stress (FSS) exposure 4 h before drinking (indicated by
∆), an injection of the KOR agonist U50,488 (5 mg/kg) 1 h before drinking
(indicated by ◦), or a saline injection 1 h before drinking (non-stressed control
group). During each test week in Experiment 2, CIE and CTL mice were
assigned to one of four conditions defined by the 2 × 2 design: FSS or no
stress (indicated by ∆) 4 h before drinking and an injection of LY2444296
(5 mg/kg) or vehicle 30 min before drinking (indicated by ×). During Tests 1–3
of Experiment 3, CIE and CTL mice received an injection of U50,488 (0, 1.25,
2.5, or 5 mg/kg) 1 h before drinking (indicated by ◦). Mice were not treated
during Tests 4–5 (washout). During Test 6, CIE and CTL mice were assigned
to one of four conditions: pretreatment with LY2444296 (5 mg/kg) or vehicle
1.5 h before drinking (indicated by ×) and administration of U50,488 (5 mg/kg)
or vehicle 1 h before drinking (indicated by ◦).
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Experiment 1
This experiment was designed to directly compare the effects of
daily FSS exposure and daily administration of the KOR agonist
U50,488 on ethanol consumption in CIE and CTL mice. A total
of 67 mice were assigned to one of six experimental conditions
(n = 11–12/group) defined by the 2 Group (CIE, CTL) × 3
Stress (No-Stress, FSS, U50,488) factorial design. FSS exposure
occurred 4 h before each daily drinking test session. U50,488
(5 mg/kg, i.p.) was injected 60 min prior to the start of each daily
drinking test session. Mice in the no-stress condition received a
saline injection at this time.
Experiment 2
This experiment was designed to examine effects of KOR
blockade on ethanol consumption in stressed (FSS) and non-
stressed mice with a history of either CIE or air exposure. A
total of 84 mice were assigned to one of eight experimental
conditions defined by the 2 Group (CIE, CTL) × 2 Stress
(No-Stress, FSS) × 2 Dose (0, 5 mg/kg LY2444296) factorial
design (n = 7–12/group). As in Experiment 1, mice in the stress
condition were exposed to 10-min FSS 4 h before each daily
test drinking session. Mice also received injections of the KOR
antagonist LY2444296 (5 mg/kg, i.p.) or vehicle 30 min prior to
the start of the 1 h drinking test sessions. Immediately following
the final 1 h drinking session, blood samples were collected and
assayed for blood ethanol concentration, as described above.
Experiment 3
This experiment was designed to generate a dose-response
function for the KOR agonist U50,488 to more fully examine
the effects of this treatment on ethanol consumption in CIE
and CTL groups of mice. A total of 80 mice were used, with
10 mice per experimental condition. During each drinking test
week, separate groups of CIE and CTL mice were administered
one of four doses of U50,488 (0, 1.25, 2.5, or 5.0 mg/kg, i.p.)
60 min prior to each daily drinking test (n = 10/group). After
Test Week 3, mice continued with two additional cycles of CIE
(or air) exposure, but only saline injections were administered to
all mice during Test Weeks 4 and 5 (drug-free washout). Prior
to Test Week 6, all subjects within CIE and CTL conditions
were re-sorted to equate ethanol intake during Test Week 5
and assigned to new drug treatment conditions based on a 2
LY2444296 Pretreatment (0, 5 mg/kg) × 2 U50,488 Treatment
(0, 5 mg/kg) design. LY2444296 pretreatment was given 60 min
prior to the 1 h drinking session and 30 min prior to U50,488
treatment.
RESULTS
Experiment 1
Drinking data were expressed as average weekly ethanol intake
(g/kg) and analyzed by a 3-way ANOVA, with Group (CIE, CTL)
and Stress (No-Stress, FSS, U50,488) as between-subject factors
and Week (Baseline, Test 1, Test 2, Test 3) as a repeated measure.
This analysis revealed main effects of Group [F(1,61) = 7.61,
p < 0.01], Stress [F(2,61) = 24.593, p < 0.001], and Week
[F(3,183) = 24.489, p < 0.001], in additional to a significant
Stress × Week interaction [F(6,183) = 8.804, p < 0.01]. Post hoc
analyses indicated that U50,488 significantly increased ethanol
consumption relative to baseline levels of intake as well as intake
in both No-Stress and FSS groups during all three test weeks
(p’s< 0.05).
To further explore potential differences between CIE and CTL
mice, data were separately analyzed for each ethanol exposure
condition. Analysis of CTL mice revealed significant main effects
of Stress [F(2,31) = 13.784, p < 0.001] and Week [F(3,93) = 9.945
p < 0.001], and a Stress × Week interaction [F(6,93) = 5.73,
p < 0.001]. Post hoc tests indicated that U50,488 treatment
increased drinking relative to baseline and relative to both No-
Stress and FSS groups during all three test weeks. No changes
were observed for either FSS-exposed or No-Stress mice.
Analysis of CIE mice revealed significant main effects of
Stress [F(2,30) = 12.428, p < 0.001] and Week [F(3,90) = 15.154,
p< 0.001], as well as a Stress×Week interaction [F(6,90) = 4.577,
p < 0.001]. Post hoc tests indicated that mice exposed to FSS
increased consumption relative to baseline during Tests 1–3.
Mice in the U50,488 group increased consumption relative
to baseline and relative to the No-Stress group during Tests
1–3 (p’s < 0.05). During Test 3, mice in the U50,488 group
also consumed more ethanol than mice in the FSS condition
(p = 0.05). No changes were observed in the No-Stress condition.
Data are shown in Figure 2.
Experiment 2
Drinking data were expressed as average weekly ethanol intake
(g/kg) and analyzed using a 2 (Group) × 2 (Stress) × 2
(LY2444296 Dose) × 4 (Week) repeated measures ANOVA.
The analysis revealed a significant Group × Stress × Dose
× Week interaction [F(3,210) = 2.75, p < 0.05]. Post hoc
tests indicated no significant differences in drinking among
CTL groups of mice during baseline or any of the test
weeks. In contrast, vehicle-treated FSS-exposed mice with a
history of CIE exposure demonstrated a significant increase
in drinking above baseline levels during all three test weeks.
These vehicle-treated CIE-FSS mice also consumed more
ethanol than CIE-NS mice during Test 3 and more ethanol
than CTL-FSS mice during Tests 2–3 (p’s < 0.05). While
the KOR antagonist did not alter drinking in CTL mice,
pretreatment with LY2444296 abolished FSS-enhanced drinking
in CIE-exposed mice during all three test weeks of the study
(Figure 3).
BEC data from the final drinking session during Test 3 were
analyzed by a 2 (Group) × 2 (Stress) × 2 (LY2444296 Dose)
factorial ANOVA, which revealed a significant Group × Stress
× Dose interaction [F(1,58) = 4.08, p < 0.05]. Further analyses
indicated that CIE-FSS mice registered significantly higher BECs
than mice in all other conditions (Figure 4). No other group
differences were observed.
Experiment 3
Average weekly ethanol intake (g/kg) was analyzed using a 2
(Group) × 4 (U50,488 Dose) × 4 (Week) repeated measures
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FIGURE 2 | Average weekly ethanol consumption (g/kg). Among air-exposed control (CTL) mice, administration of the KOR agonist U50,488 (5 mg/kg) resulted
in elevated ethanol intake relative to baseline (indicated by ∧), non-stressed (NS) mice (indicated by ∗), and forced swim stress-exposed (FSS) mice (indicated by +)
during all three test weeks. Among mice exposed to chronic intermittent ethanol (CIE), administration of U50,488 resulted in elevated ethanol intake relative to
baseline (indicated by ∧) and non-stressed mice (indicated by ∗) during Tests 1–3, and relative to FSS mice during Test 3 (indicated by +). FSS mice demonstrated
elevated ethanol consumption relative to baseline during all three test weeks (indicated by ∧).
FIGURE 3 | Average weekly ethanol consumption (g/kg). Among air-exposed control (CTL) mice, no effects of stress, chronic ethanol exposure (CIE), or KOR
blockade were observed. Among CIE-exposed mice, FSS exposure (solid black bars) increased ethanol consumption relative to baseline consumption during all
three test weeks (indicated by ∧), relative to CTL-FSS mice during Tests 2–3 (indicated by +), and relative to CIE-NS mice during Test 3 (indicated by ∗). Pretreatment
with the KOR antagonist LY2444296 (striped black bars) blocked the FSS-induced increased drinking in CIE mice and resulted in a significant reduction from
CIE-FSS vehicle mice during Test 3 (indicated by #).
ANOVA, which revealed significant main effects of Group
[F(1,72) = 4.50, p < 0.05], Dose [F(3,72) = 14.75, p < 0.01],
and Week [F(3,216) = 53.81, p < 0.01], as well as Group
× Week [F(3,216) = 2.82, p < 0.05] and Dose × Week
[F(9,216) = 8.57, p < 0.01] interactions. Post hoc analyses
indicated that U50,488 administration significantly increased
ethanol consumption above baseline levels in both CIE and CTL
groups during all test weeks. Additionally, U50,488 increased
ethanol intake compared to the vehicle condition in CIE and
CTL mice, an effect that did not significantly differ as a function
of dose. The increase in ethanol consumption induced by
treatment with the KOR agonist appeared to be greater in CIE
mice compared to CTL mice (especially during the last test
week), but this effect did not achieve statistical significance
(Figure 5).
Analysis of average weekly ethanol intake (g/kg) during
the drug washout evaluation period (Test Weeks 4 and 5;
saline injections only) indicated that the effects of U50,488
treatment dissipated prior to the final Test Week. Specifically,
ANOVA revealed a significant Dose × Week interaction
[F(3,71) = 3.361, p < 0.05]. Post hoc analysis indicated that
mice previously exposed to any of the U50,488 doses during
Test Weeks 1–3 continued to demonstrate elevated ethanol
consumption relative to vehicle-exposed mice during Test
Week 4. This residual drug effect was no longer observed the
following week (Test Week 5). Thus, the increased ethanol
consumption induced by previous U50,488 administration
persisted for 1 week beyond treatment (Test 4) before
subsiding during the second washout week (Test 5; data not
shown).
Average weekly ethanol intake (g/kg) during Test
Week 6 was analyzed using a 2 (Group) × 2 (LY2444296
dose) × 2 (U50,488 dose) factorial ANOVA. This analysis
revealed significant main effects of LY2444296 Pretreatment
[F(1,71) = 5.90, p < 0.05] and U50,488 Treatment [F(1,71) = 5.46,
p < 0.05], as well as the interaction between these factors
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 February 2016 | Volume 10 | Article 45
Anderson et al. Stress-Induced Ethanol Consumption
FIGURE 4 | Blood ethanol concentrations (BECs) following the final
drinking session. Vehicle-treated CIE-FSS mice had higher BECs than
CIE-NS mice (indicated by ∗) and CTL-FSS mice (indicated by +). The
FSS-induced increase in BEC was blocked by pretreatment with LY2444296,
which resulted in significantly lower BECs than vehicle-treated CIE-FSS mice
(indicated by #).
[F(1,71) = 6.65, p < 0.05]. Post hoc analyses indicated that
among vehicle-pretreated CIE and CTL mice, U50,488
(5 mg/kg) produced a significant increase in drinking.
However, LY2444296 (5 mg/kg) pretreatment blocked this
effect of the KOR agonist in both CIE and CTL groups of mice
(Figure 6).
DISCUSSION
Results from the current series of experiments support a
role for the dynorphin/KOR system in mediating stress-
induced enhancement of ethanol drinking in mice with a
history of dependence (CIE exposure). As we previously
demonstrated (Lopez et al., 2016), daily exposure to FSS
selectively increased ethanol consumption in CIE-exposed
mice but did not alter drinking in nondependent (CTL)
mice (Experiments 1 and 2). This stress effect was blocked
by administration of the KOR antagonist LY2444296
(Experiment 2). Additionally, the effects of FSS were mimicked
by administration of the KOR agonist U50,488. However,
whereas FSS increased drinking only in CIE-exposed mice,
pharmacological activation of KORs increased drinking in
both CIE-exposed and CTL mice (Experiments 1 and 3).
While the dynorphin/KOR system has been implicated
in drinking in ethanol-dependent animals and stress-
related behaviors, this study provides the first evidence
that this system plays a role in the capacity of stressful
experiences to selectively enhance drinking in dependent
subjects.
Forced Swim Stress Exposure Selectively
Increases Ethanol Consumption in Mice
with a History of Chronic Intermittent
Ethanol Treatment
Results from the first and second experiments of the current
study replicated our previous findings demonstrating that
daily FSS exposure increases ethanol consumption in mice
with a history of dependence (CIE exposure), but not in
nondependent (air-exposed) controls (Lopez et al., 2016).
A similar effect of FSS has been reported in rats given
24 h access to ethanol, with elevated consumption observed
during and following FSS exposure in dependent (but not
control) rats (Sommer et al., 2008). In the present study,
FSS increased drinking in CIE-exposed mice on the same
days that the stress exposure occurred, and this increase in
ethanol consumption resulted in a nearly threefold increase
in BECs. Of note, other studies have reported stress-induced
increases in ethanol drinking in nondependent mice, but this
effect was only observed when ethanol was made available
for consumption after exposure to the stressor was terminated
(e.g., Sillaber et al., 2002; Lowery et al., 2008; Norman
et al., 2015; Hwa et al., 2016). Taken together, these results
highlight the importance of the timing of stress exposure
in relation to ethanol access, and also indicate that stress
exposure (FSS in the present study) interacts with chronic
ethanol exposure and withdrawal experience in a unique
manner to promote elevated drinking in the context of
dependence.
FIGURE 5 | Average weekly ethanol consumption (g/kg). All doses of the KOR agonist U50,488 resulted in elevated ethanol consumption relative to baseline
drinking (indicated by ∧) and vehicle-injected controls (indicated by ∗) during Tests 1–3 for both CIE and CTL mice.
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FIGURE 6 | Average ethanol consumption during final test week (g/kg).
For both CIE and CTL mice administered 5 mg/kg U50,488, pretreatment with
the KOR antagonist LY2444296 blocked the increase in drinking observed in
vehicle-treated mice (indicated by ∗).
KOR Blockade Prevents Stress-Induced
Elevation of Drinking in Mice with a History
of Chronic Intermittent Ethanol Treatment
Systemic administration of the KOR antagonist LY2444296
(5 mg/kg) prior to each drinking session blocked the FSS-induced
increase in ethanol consumption observed in CIE-exposed mice.
To our knowledge, this is the first evidence demonstrating
that pharmacological antagonism of KORs prevents stress-
induced increases in ethanol consumption. Previous studies
have reported that other KOR antagonists reduce ethanol
consumption in various models. For instance, the long-acting
KOR antagonist nor-BNI was shown to block escalation of
ethanol consumption induced by chronic vapor exposure in
rats (Walker and Koob, 2008; Walker et al., 2011) and
mice (Rose et al., 2015). JDTic was reported to attenuate
ethanol-seeking behavior in nondependent Wistar and P-rats
(Deehan et al., 2012; Schank et al., 2012), and another short-
acting antagonist, LY2456302 was shown to reduce ethanol
consumption in P rats (Rorick-Kehn et al., 2014). However,
it is difficult to compare the effects of KOR blockade across
studies, particularly since only one dose of the novel antagonist
was tested in the current report. It will be important to test
additional doses of LY2444296 in this model to determine
whether higher doses reduce ethanol consumption in non-
stressed subjects as well. While LY2444296 was effective in
blocking stress-induced enhancement of drinking in CIE-
exposed mice in the present study, the lack of an effect of this
KOR antagonist on drinking in non-stressed CIE mice may
be due to the 1 h drinking paradigm used that did not favor
escalated intake. At present, it is unclear why some studies have
demonstrated KOR antagonists to reduce ethanol consumption
in nondependent animals (Deehan et al., 2012; Schank et al.,
2012; Rorick-Kehn et al., 2014), while other studies indicate more
selective attenuating effects for elevated drinking associated with
dependence (Walker and Koob, 2008; Walker et al., 2011; Rose
et al., 2015).
Because the KOR antagonist was administered after FSS
exposure and prior to each ethanol drinking session in the
present study, it is possible that the stress experience may have
rendered mice more sensitive to the KOR manipulation. On the
other hand, it may be that the KOR antagonist reduced stress-
enhanced drinking in CIE mice by alleviating consequences
of stress exposure (e.g., negative affect) that contribute to the
elevation in drinking. Future studies that systematically examine
the temporal relationship between stress experience, KOR
antagonism, and ethanol access will be critical for addressing this
issue.
KOR Activation Increases Ethanol
Consumption in Dependent and
Nondependent Mice
Similar to the effects of FSS, systemic administration of the KOR
agonist U50,488 significantly increased ethanol consumption in
CIE-exposed mice; however, this effect was also observed in
air-exposed control subjects. This finding was confirmed in a
follow-up study (Experiment 3) that evaluated a wider range
of U50,488 doses, but the increase in ethanol consumption did
not vary as a function of dose. This was a surprising outcome
given that the low doses of U50,488 evaluated in the present
study have not previously been reported to influence drug
reward (Schindler et al., 2010; Smith et al., 2012). Future studies
will need to assess even lower doses of U50,488 to generate
a dose-effect function and determine whether CIE and CTL
mice exhibit differential sensitivity to the KOR agonist in this
drinking model.
Our results are generally consistent with other studies
that demonstrated similar behavioral effects of U50,488
and stress exposure on conditioned ethanol reward and
consumption (Sperling et al., 2010), although it is unclear
why only CIE-exposed mice were sensitive to FSS-induced
increased drinking whereas both CIE and CTL mice were
sensitive to the KOR agonist-induced increased drinking.
Results from Experiments 1 and 3 also indicate that
U50,488 produced a more robust elevation of ethanol
consumption than FSS. It may be that direct pharmacological
stimulation of KORs produces a general increase in ethanol
consumption whereas FSS produces more complex effects
than simply activating KORs. This, in turn, may explain
why FSS interacts in a unique manner with CIE exposure
to selectively increase drinking in dependent compared to
nondependent mice. Thus, while systemic administration
of a KOR antagonist completely blocked the ability of FSS
to selectively enhance drinking in CIE-exposed mice, the
mechanisms underlying this stress-CIE exposure interaction
remain to be fully elucidated.
Possible Mechanisms Underlying KOR
Modulation of Stress-Ethanol Interactions
As noted above, the attenuation of stress-enhanced drinking in
CIE mice by KOR antagonism may reflect one of several possible
underlying mechanisms. We postulate that repeated cycles of
CIE exposure combined with repeated FSS exposure activate
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the dynorphin/KOR system within brain stress circuitry, and
that behavioral manifestations of this effect can be attenuated
by blocking KORs. Indeed, chronic ethanol exposure has been
reported to sensitize KORs in the nucleus accumbens core in
monkeys and mice (Rose et al., 2015; Siciliano et al., 2015).
Similarly, social isolation stress has been shown to sensitize these
receptors in rats (Karkhanis et al., 2016). An alternative, but not
mutually exclusive, explanation is based on the observation that
stress exposure can enhance sensitivity to ethanol withdrawal
symptoms (i.e., promoting escalated drinking via negative
reinforcement). In this case, KOR blockade may prevent
escalated drinking by attenuating ethanol withdrawal symptoms.
Support for this idea comes from evidence indicating that
KOR antagonists can attenuate withdrawal-related anxiety and
other signs of negative affect (Schank et al., 2012; Valdez and
Harshberger, 2012; Berger et al., 2013), without altering physical
symptoms of dependence (Kissler and Walker, 2015).
Increased activity of the dynorphin/KOR system within the
amygdala has been suggested to play a significant role in
mediating the negative emotional aspects of chronic ethanol
exposure and withdrawal (e.g., Valdez and Harshberger, 2012;
Berger et al., 2013). Thus, the amygdala appears to be a
primary brain region for KOR modulation of stress interactions
with the motivational effects of ethanol. A study that assessed
c-Fos activation following footshock stress in wild-type and
prodynorphin knockout mice with or without a long history
of ethanol consumption implicated the basolateral amygdala
(BLA) as a potential locus of dynorphin-mediated interactions
of stress and ethanol (Rácz et al., 2013). Among wild-type
mice in this study, a history of chronic ethanol consumption
resulted in greater stress-induced c-Fos activation in the BLA
relative to their ethanol-naïve counterparts. Conversely, among
prodynorphin knockout mice, stress-induced c-Fos activation
was blunted in ethanol-exposed mice compared to ethanol-naïve
subjects (Rácz et al., 2013). The CeA also appears to be an
important brain region where KORs exert effects on ethanol-
related signaling (Kang-Park et al., 2013; Gilpin et al., 2014;
Kissler et al., 2014). Site-specific administration of the KOR
antagonist nor-BNI has been shown to reduce chronic ethanol-
induced escalated ethanol consumption.
Interestingly, increased activity of another stress-related
peptide system, CRF, in the CeA has been implicated in
stress and motivational effects of ethanol associated with
dependence (Funk et al., 2006; Finn et al., 2007; Heilig and
Koob, 2007; Becker, 2012). Further, recent work has suggested
interactions between KOR and CRF systems in the CeA that
influence ethanol’s effects on GABA-ergic transmission (Kang-
Park et al., 2015). As numerous studies have demonstrated
that interactions of dynorphin and CRF can influence stress,
anxiety, and drug-seeking behavior (e.g., Valdez et al., 2007;
Land et al., 2008; Bruchas et al., 2009; Funk et al., 2014),
the potential interaction between these peptide systems in
mediating stress-enhancement of drinking in the context of
dependence should be addressed in future studies. Further,
evidence that KORs interact with noradrenergic and serotonergic
signaling to regulate the influence of stress on drug reward and
reinstatement (Land et al., 2009; Al-Hasani et al., 2013) suggests
that the effects of KOR manipulation on stress-induced ethanol
consumption may reflect integrated effects mediated through
multiple neurotransmitter systems. Additional research will be
required to elucidate the precise mechanisms by which KOR
blockade abolishes stress-induced drinking in subjects with a
history of chronic ethanol exposure.
Therapeutic Potential of KOR Antagonists
for Treatment of Alcohol Use Disorder
Results of the current study provide evidence that
pharmacological manipulation of KOR activity can modulate
stress-induced increases in ethanol consumption in mice with
a history of CIE exposure. As such, these results suggest that
KORs may be a promising target for therapeutic intervention
of alcoholism, particularly among individuals that engage in
harmful levels of drinking that is principally driven by stressful
experiences.
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